[Discussion] the CagriSema advice in here is 14 years out of date
Long-ish post, sorry. tl;dr at the bottom. I have been tracking cagrilintide against ApoB for 17 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
Tracking number removed. It identifies both ends of a shipment.
amylin is not a GLP-1, posts conflating them get corrected
Small correction: the trial was 6 weeks, not 4. Does not change your point but people will quote it.
the mechanism is different, the side effect profile reflects it
Small correction: the trial was 15 weeks, not 26. Does not change your point but people will quote it.
CagriSema ratios in trials are fixed, do not extrapolate self-mixing
the amylin agonist pool is small, community is amylin
REDEFINE phase 16 readouts are interesting but 16 person cagrilintide is different from 16 trial cagrilintide.